Back

Cognitively Healthy Centenarian Brains resist Tau Accumulation and exhibit lower APOE, early proteasome response and maintained β-oxidation.

Hulsman, M.; Ganz, A. B.; Zhang, M.; Koopmans, F.; Li, K. W.; Miedema, S. S. M.; Rohde, S. K.; Luimes, M. C.; Morrema, T. H. J.; Rozemuller, A. J. M.; Scheltens, P.; Hoozemans, J.; Reinders, M.; Smit, A. B.; Holstege, H.

2026-01-08 neurology
10.64898/2026.01.08.26343581
Show abstract

Brains from cognitively intact centenarians offer a unique window into mechanisms of neuroprotection. We quantified 3,448 proteins by LC-MS/MS in middle temporal gyrus (MTG) from 88 Alzheimers disease (AD) patients, 53 controls (50-99 years) and 49 centenarians (100+). After adjustment for cell type composition, A{beta} abundance associated with only five proteins, revealing upregulation of HTRA1, LRP1 and NRXN1 as early AD-associated changes. Conversely, tau abundance associated with [~]20% of the quantified proteome, revealing GPRIN1 as the top tau-associated protein. One-third of centenarians had high A{beta} abundance, often with Braak neurofibrillary tangle stages IV/V, yet all maintained low local tau abundance. Centenarians showed maintained proteostasis (low ubiquitin peptides, high proteasome components), high PCSK1 (prohormone maturation), high PFKFB2 (glycolysis regulation), mitochondria-coupled lipid {beta}-oxidation and lower APOE levels. Together, these findings suggest a model of neuroprotection in which A{beta} facilitates tau seeding, and where proteostatic and metabolic adaptations buffer against additional tau accumulation in centenarians.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.